Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Moberg Derma has signed a distribution agreement with Ana Darou for Nalox/Emtrix, which is indicated for discolored and damaged nails caused by nail fungus (onychomycosis) or nail psoriasis, in Iran.
Subscribe to our email newsletter
Under the agreement, Ana Darou gained exclusive rights to market and sell Nalox/Emtrix in Iran while Moberg assumes production and supply responsibility.
Moberg Derma CEO and founder Peter Wolpert said the agreement is part of the company’s international commercialization of Nalox/Emtrix.
"We are looking forward to make the product available to the patients in Iran through the cooperation with Ana Darou," Wolpert added.
Nalox is a prescription free, over-the-counter product sold under the name Emtrix in certain markets and under the name Kerasal Nail in the US.